RELINIFY
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

RELINIFY Trademark

Serial Number: 50114329

RELINIFY is a trademark filed by Takeda Pharmaceuticals U.S.A., Inc. on September 17, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Takeda Pharmaceuticals U.S.A., Inc.

500 Kendall Street
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

September 17, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders.

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 17, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 17, 2026 NWOS
NEW APPLICATION ENTERED
Sep 17, 2026 NWAP